» Articles » PMID: 31374926

Analytical and Computational Methods for the Estimation of Drug-Polymer Solubility and Miscibility in Solid Dispersions Development

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2019 Aug 4
PMID 31374926
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The development of stable solid dispersion formulations that maintain desired improvement of drug dissolution rate during the entire shelf life requires the analysis of drug-polymer solubility and miscibility. Only if the drug concentration is below the solubility limit in the polymer, the physical stability of solid dispersions is guaranteed without risk for drug (re)crystallization. If the drug concentration is above the solubility, but below the miscibility limit, the system is stabilized through intimate drug-polymer mixing, with additional kinetic stabilization if stored sufficiently below the mixture glass transition temperature. Therefore, it is of particular importance to assess the drug-polymer solubility and miscibility, to select suitable formulation (a type of polymer and drug loading), manufacturing process, and storage conditions, with the aim to ensure physical stability during the product shelf life. Drug-polymer solubility and miscibility can be assessed using analytical methods, which can detect whether the system is single-phase or not. Thermodynamic modeling enables a mechanistic understanding of drug-polymer solubility and miscibility and identification of formulation compositions with the expected formation of the stable single-phase system. Advance molecular modeling and simulation techniques enable getting insight into interactions between the drug and polymer at the molecular level, which determine whether the single-phase system formation will occur or not.

Citing Articles

Application of the Box-Behnken Design in the Development of Amorphous PVP K30-Phosphatidylcholine Dispersions for the Co-Delivery of Curcumin and Hesperetin Prepared by Hot-Melt Extrusion.

Wdowiak K, Tajber L, Miklaszewski A, Cielecka-Piontek J Pharmaceutics. 2025; 17(1).

PMID: 39861675 PMC: 11768460. DOI: 10.3390/pharmaceutics17010026.


The Increase in the Plasticity of Microcrystalline Cellulose Spheres' When Loaded with a Plasticizer.

Paulausks A, Kolisnyk T, Mohylyuk V Pharmaceutics. 2024; 16(7).

PMID: 39065642 PMC: 11279479. DOI: 10.3390/pharmaceutics16070945.


System-agnostic prediction of pharmaceutical excipient miscibility via computing-as-a-service and experimental validation.

Antipas G, Reul R, Voges K, Kyeremateng S, Ntallis N, Karalis K Sci Rep. 2024; 14(1):15106.

PMID: 38956156 PMC: 11219749. DOI: 10.1038/s41598-024-65978-2.


Sweeteners Show a Plasticizing Effect on PVP K30-A Solution for the Hot-Melt Extrusion of Fixed-Dose Amorphous Curcumin-Hesperetin Solid Dispersions.

Wdowiak K, Tajber L, Miklaszewski A, Cielecka-Piontek J Pharmaceutics. 2024; 16(5).

PMID: 38794322 PMC: 11124940. DOI: 10.3390/pharmaceutics16050659.


Advancements in nanoscale delivery systems: optimizing intermolecular interactions for superior drug encapsulation and precision release.

Dong E, Huo Q, Zhang J, Han H, Cai T, Liu D Drug Deliv Transl Res. 2024; 15(1):7-25.

PMID: 38573495 DOI: 10.1007/s13346-024-01579-w.


References
1.
Greenhalgh D, Williams A, Timmins P, York P . Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci. 1999; 88(11):1182-90. DOI: 10.1021/js9900856. View

2.
Forster A, Hempenstall J, Tucker I, Rades T . Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm. 2001; 226(1-2):147-61. DOI: 10.1016/s0378-5173(01)00801-8. View

3.
Crowley K, Zografi G . Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions. J Pharm Sci. 2002; 91(10):2150-65. DOI: 10.1002/jps.10205. View

4.
Shmeis R, Wang Z, Krill S . A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part I: a comparative analysis by thermally stimulated depolarization current and differential scanning calorimetry. Pharm Res. 2004; 21(11):2025-30. DOI: 10.1023/b:pham.0000048193.94922.09. View

5.
Karavas E, Ktistis G, Xenakis A, Georgarakis E . Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions. Drug Dev Ind Pharm. 2005; 31(6):473-89. DOI: 10.1080/03639040500215958. View